• Home
  • About
  • Services
  • Contact
  • Media

2022 Review: Sectors, Stocks & International

Posted January 20, 2023 by Denis Smirnov

Continuing with my 2022 year-in-review series (first post), let’s take a look at U.S. sectors and industries (Exhibit 1). Former darlings in Internet, Consumer Discretionary, Semis and Retail all declined over 30% last year. Tech, homebuilders and real estate didn’t do much better. The stars of 2022 sector show were energy stocks with XLE up 64%! Steel also had a strong rebound. Classic defensive sectors of utilities, consumer staple and healthcare were flat as talk of imminent recession dominated the news flow. Even after a rough year technology and other 2022 dogs still have stellar 10-year returns while the energy winners are still far behind on the longer timeframes. This may mean that the current sector rotation pattern has some legs (or not).

Exhibit 1 – 2022 Performance for Domestic Sectors & Industries

Let’s also take a look at some individual stocks. Exhibit 2 shows 20 best performing companies in the S&P 500. It’s pretty much ALL energy with couple of solar plays and a steel maker. Remember when Zoom had a larger market cap than Exxon (they crossed around $140 billion back in 2020)? Well, XOM is now worth $463 billion versus $20 billion for ZM. Surprisingly, there are also couple of medical distributors on the list driven by name-specific fact0rs.

Exhibit 2 – 2022 Top Performing S&P 500 Stocks

The worst 20 stocks in the S&P 500 are shown in (Exhibit 3). This list is a hodge podge of stocks from all corners of the market and, unlike the winners, there is no consistent theme here. There is a generator company, a dating site, few banks, PayPal, several media companies, travel/gaming stocks, etc.  There are two notable giants that fell from grace in 2022 – Tesla and Meta (formerly Facebook). Both had market values of over a trillion dollars at one point but have since dropped into the $300 billion range. And these are the blue chip names – there are plenty of former high flyers that dropped 80%+ last year – Lucid, Rivian, Coinbase, Snapchat, Wayfair, Peloton, etc., etc. The moral here is that you need to be very active in watching your big winner lest they roll over hard and lose everything. That’s why indexing works so well over the long run.

Exhibit 3 – 2022 Bottom Performing S&P 500 Stocks

On the international front, USA’s 18% loss put it in the middle of the pack. Russia’s stock market completely self-destructed when its invasion of Ukraine triggered western economic sanctions. RSX which held US-traded Russian stocks just liquidated and lost 100% of its value. Still painful but less severe were losses around Asia (Vietnam, Taiwan, China, South Korea), Middle East and Europe. Best performers were Turkey (+106%!), Chile, Brazil, Argentina, Greece & Peru.

But then again, if we look at 10-year returns, US is still the best by far. However, there seems to be a distinct change in relative performance of US and foreign stocks that started in November 2022 and coincided with the peak of US Dollar. Whether this is a start of a new trend or just a short-term blip remains to be seen, but I’ll definitely be keeping an eye on it.

Exhibit 4 – 2022 Single Country Performance

I’ll finish the annual reviews by looking at the economic numbers when GDP is released at the end of next week.

Share this:

  • Facebook
  • LinkedIn
  • Twitter
  • Pocket
  • Email

Sign up to the newsletter

Categories

  • Bear Markets
  • Bonds
  • Economy
  • Education
  • Financial Planning
  • Indexing
  • Investing
  • IPO
  • Retirement
  • Taxes
  • Uncategorized
  • Valuation

Archives

  • January 2023
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • May 2022
  • April 2022
  • February 2022
  • January 2022
  • October 2021
  • September 2021
  • July 2021
  • February 2021
  • January 2021
  • November 2020
  • October 2020
  • September 2020
  • July 2020
  • June 2020
  • May 2020
  • March 2020
  • February 2020
  • January 2020
  • November 2019
  • October 2019
  • September 2019
  • July 2019
  • May 2019
  • February 2019
  • January 2019
  • December 2018
  • October 2018
  • September 2018
  • July 2018
  • June 2018
  • May 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014
  • September 2014
  • August 2014
  • July 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • January 2014
  • December 2013
  • October 2013
About
  • Background
  • Who We Are
  • The Gordian Knot
Services
  • Services
  • Planning Process
  • Investment Philosophy
Contact
  • Contact Details
  • Inquiry Form
  • Map
Media
  • Articles
  • Blog
  • Reviews
Dave
Denis
 
 
 
 

Gordian Advisors Financial Planner

Office: 2200 E. River Rd., Suite 109, Tucson, AZ 85718

Phone: 520-615-2779

Email: info@gordianadvisors.com

Download Form Form CRS Client Relationship Summary

Download Form ADV Disclosure Brochure

Gordian Advisors may only transact business or render personalized investment advice in those states where we are registered, or have filed notice, or are otherwise excluded or exempted from registration requirements. Material discussed is meant for general illustration and/or informational purposes only, and is not to be construed as investment advice. Nothing on this web-site should be interpreted to state or imply that past results are an indication of future performance. Although this information has been gathered from sources believed to be reliable, please note that individual situations may vary. Therefore, any information should be relied upon only when coordinated with individual professional advice.